Stueland Katherine
GeneDx Holdings Corp. · CHIEF EXECUTIVE OFFICER
Stueland Katherine is listed in filings as CHIEF EXECUTIVE OFFICER at GeneDx Holdings Corp.. This profile follows SEC Form 4 activity through May 1, 2026, including sale activity. Recent filings connect the profile to GeneDx Holdings Corp. (WGS). The current snapshot covers public activity from May 1, 2025 to May 1, 2026. Reported amounts are shown as $1.2K to $848.7K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $1.2k18 shares | SellApr 29, 2026 | $64.12 | $61.65 | |
| $140k2.2k shares | SellApr 29, 2026 | $65.20 | $61.65 |